Download PDF
Thorac Cardiovasc Surg 2019; 67(05): 402-406
DOI: 10.1055/s-0038-1668599
Original Thoracic
Georg Thieme Verlag KG Stuttgart · New York

CT-Guided Chemical Thoracic Sympathectomy versus Botulinum Toxin Type A Injection for Palmar Hyperhidrosis

HongJun Yang   *
1   Department of Neurology, General Hospital of Guangzhou Military Command of PLA, Guangzhou, Guangdong, People's Republic of China
,
Jianjie Kang   *
1   Department of Neurology, General Hospital of Guangzhou Military Command of PLA, Guangzhou, Guangdong, People's Republic of China
,
Shufen Zhang
1   Department of Neurology, General Hospital of Guangzhou Military Command of PLA, Guangzhou, Guangdong, People's Republic of China
,
Kairun Peng
1   Department of Neurology, General Hospital of Guangzhou Military Command of PLA, Guangzhou, Guangdong, People's Republic of China
,
Bingmei Deng
1   Department of Neurology, General Hospital of Guangzhou Military Command of PLA, Guangzhou, Guangdong, People's Republic of China
,
Biao Cheng
2   Department of Plastic Surgery, General Hospital of Guangzhou Military Command of PLA, Guangzhou, Guangdong, People's Republic of China
› Author Affiliations Funding This work was supported by the Natural Science Foundation of Guangdong Province [grant number 2017A030313838] and the Military Medical Foundation [grant number CWS11J2722].
Further Information

Publication History

06 April 2018

11 July 2018

Publication Date:
14 September 2018 (online)

    Permissions and Reprints All articles of this category

Abstract

Background The present study aimed to evaluate and compare the efficacy of botulinum toxin type A (BTX-A) injection versus thoracic sympathectomy for idiopathic palmar hyperhidrosis.

Methods Fifty-one patients with idiopathic palmar hyperhidrosis were treated with either BTX-A injection or thoracic sympathectomy between March 2013 and April 2016. The severity of palmar hyperhidrosis was qualitatively measured via the Hyperhidrosis Disease Severity Scale (HDSS). All patients completed a questionnaire that detailed the time taken for the treatment to work, local or systemic adverse effects, and pre- and post-treatment severity of hyperhidrosis. The efficacy and adverse effects of the two treatments were compared and analyzed.

Results Hyperhidrosis-related quality of life improved quickly and significantly in the BTX-A group (26 patients) and the sympathectomy group (25 patients). Compared with pre-treatment, the HDSS score significantly reduced after treatment in both groups (p < 0.05). All patients in the sympathectomy group had cessation of sweating of the hands after treatment, and this curative effect lasted for 12 months. In contrast, the treatment took more time to work in the BTX-A group, and the curative effect lasted for a much shorter period (3 months). The sympathectomy group had a significantly lesser mean HDSS score than the BTX-A group at 1 week, 3 months, 6 months, 9 months, and 12 months after treatment (p < 0.05). The sympathectomy group experienced more complications than the BTX-A group.

Conclusion For palmar hyperhidrosis, thoracic sympathectomy is more effective and has a longer lasting curative effect than BTX-A injection, but thoracic sympathectomy has more complications.

Keywords

palmar hyperhidrosis - botulinum toxin type A (BTX-A) injection - thoracic sympathectomy

* These two authors contributed equally to this work.


 

  • References

  • 1 Li X, Chen R, Tu YR. , et al. Epidemiological survey of primary palmar hyperhidrosis in adolescents. Chin Med J (Engl) 2007; 120 (24) 2215-2217
    PubMedGoogle Scholar
  • 2 Tu Y-R, Li X, Lin M. , et al. Epidemiological survey of primary palmar hyperhidrosis in adolescent in Fuzhou of People's Republic of China. Eur J Cardiothorac Surg 2007; 31 (04) 737-739
    CrossrefPubMedGoogle Scholar
  • 3 Fujimoto T, Kawahara K, Yokozeki H. Epidemiological study and considerations of primary focal hyperhidrosis in Japan: from questionnaire analysis. J Dermatol 2013; 40 (11) 886-890
    CrossrefPubMedGoogle Scholar
  • 4 Baumgartner F. Clinical history and classic palmar hyperhidrosis. Clin Auton Res 2009; 19 (06) 317-318
    CrossrefPubMedGoogle Scholar
  • 5 Vanderhelst E, De Keukeleire T, Verbanck S, Vincken W, Noppen M. Quality of life and patient satisfaction after video-assisted thoracic sympathicolysis for essential hyperhidrosis: a follow-up of 138 patients. J Laparoendosc Adv Surg Tech A 2011; 21 (10) 905-909
    CrossrefPubMedGoogle Scholar
  • 6 Scheer F, Wins A, Kamusella P, Wiggermann P, Wissgott C, Andresen R. [Clinical importance of CT-assisted sympathicolysis in primary, focal plantar and palmar hyperhidrosis]. RoFo Fortschr Geb Rontgenstr Nuklearmed 2012; 184 (07) 624-628
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Huang B, Yao M, Zhou XY. , et al. [Therapeutic feasibility of percutaneous puncture and chemical neurolysis of thoracic sympathetic nerve block in palmar hyperhidrosis under the guidance of computed tomograph]. Zhonghua Yi Xue Za Zhi 2011; 91 (38) 2710-2713
    PubMedGoogle Scholar
  • 8 Apiliogullari B, Esme H, Yoldas B, Duran M, Duzgun N, Calik M. Early and midterm results of single-port video-assisted thoracoscopic sympathectomy. Thorac Cardiovasc Surg 2012; 60 (04) 285-289
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Ebrahim KS. Percutaneous chemical dorsal sympathectomy for hyperhidrosis. Minim Invasive Neurosurg 2011; 54 (01) 29-32
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Cerfolio RJ, De Campos JR, Bryant AS. , et al. The Society of Thoracic Surgeons expert consensus for the surgical treatment of hyperhidrosis. Ann Thorac Surg 2011; 91 (05) 1642-1648
    CrossrefPubMedGoogle Scholar
  • 11 Campanati A, Giuliodori K, Giuliano A. , et al. Treatment of palmar hyperhidrosis with botulinum toxin type A: results of a pilot study based on a novel injective approach. Arch Dermatol Res 2013; 305 (08) 691-697
    CrossrefPubMedGoogle Scholar
  • 12 Ito K, Yanagishita T, Ohshima Y, Tamada Y, Watanabe D. Therapeutic effectiveness of botulinum toxin type A based on severity of palmar hyperhidrosis. J Dermatol 2011; 38 (09) 859-863
    PubMedGoogle Scholar
  • 13 Lehman JS. Writer's block: “texting” impairment as a complication of botulinum toxin type A therapy for palmar hyperhidrosis. Arch Dermatol 2011; 147 (06) 752
    CrossrefPubMedGoogle Scholar
  • 14 Gregoriou S, Rigopoulos D, Makris M. , et al. Effects of botulinum toxin-a therapy for palmar hyperhidrosis in plantar sweat production. Dermatol Surg 2010; 36 (04) 496-498
    CrossrefPubMedGoogle Scholar
  • 15 Huang B, Sun K, Zhu Z. , et al. Oximetry-derived perfusion index as an early indicator of CT-guided thoracic sympathetic blockade in palmar hyperhidrosis. Clin Radiol 2013; 68 (12) 1227-1232
    CrossrefPubMedGoogle Scholar
  • 16 Solish N, Bertucci V, Dansereau A. , et al; Canadian Hyperhidrosis Advisory Committee. A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatol Surg 2007; 33 (08) 908-923
    PubMedGoogle Scholar
  • 17 Walling HW, Swick BL. Treatment options for hyperhidrosis. Am J Clin Dermatol 2011; 12 (05) 285-295
    CrossrefPubMedGoogle Scholar
  • 18 Lakraj AA, Moghimi N, Jabbari B. Hyperhidrosis: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins. Toxins (Basel) 2013; 5 (04) 821-840
    CrossrefPubMedGoogle Scholar
  • 19 Bushara KO, Park DM. Botulinum toxin and sweating. J Neurol Neurosurg Psychiatry 1994; 57 (11) 1437-1438
    CrossrefPubMedGoogle Scholar
  • 20 Rosell K, Hymnelius K, Swartling C. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis. Acta Derm Venereol 2013; 93 (03) 335-339
    CrossrefPubMedGoogle Scholar
  • 21 Bhidayasiri R, Truong DD. Evidence for effectiveness of botulinum toxin for hyperhidrosis. J Neural Transm (Vienna) 2008; 115 (04) 641-645
    CrossrefPubMedGoogle Scholar
  • 22 Lin TS, Fang HY. Transthoracic endoscopic sympathectomy in the treatment of palmar hyperhidrosis--with emphasis on perioperative management (1,360 case analyses). Surg Neurol 1999; 52 (05) 453-457
    CrossrefPubMedGoogle Scholar
  • 23 de Andrade Filho LO, Kuzniec S, Wolosker N, Yazbek G, Kauffman P, Milanez de Campos JR. Technical difficulties and complications of sympathectomy in the treatment of hyperhidrosis: an analysis of 1731 cases. Ann Vasc Surg 2013; 27 (04) 447-453
    CrossrefPubMedGoogle Scholar
  • 24 Rosen RJ, Miller DL, Imparato AM, Riles TS. Percutaneous phenol sympathectomy in advanced vascular disease. AJR Am J Roentgenol 1983; 141 (03) 597-600
    CrossrefPubMedGoogle Scholar
  • 25 Purtuloglu T, Atim A, Deniz S. , et al. Effect of radiofrequency ablation and comparison with surgical sympathectomy in palmar hyperhidrosis. Eur J Cardiothorac Surg 2013; 43 (06) e151-e154
    CrossrefPubMedGoogle Scholar
  • 26 Lee KS, Chuang CL, Lin CL, Tsai LC, Hwang SL, Howng SL. Percutaneous CT-guided chemical thoracic sympathectomy for patients with palmar hyperhidrosis after transthoracic endoscopic sympathectomy. Surg Neurol 2004; 62 (06) 501-505 , discussion 505
    CrossrefPubMedGoogle Scholar
  • 27 Fiorelli A, D'Aponte A, Canonico R. , et al. T2-T3 sympathectomy versus sympathicotomy for essential palmar hyperhidrosis: comparison of effects on cardio-respiratory function. Eur J Cardiothorac Surg 2012; 42 (03) 454-461
    CrossrefPubMedGoogle Scholar